Annalisa Jenkins - Feb 29, 2024 Form 3 Insider Report for Skye Bioscience, Inc. (SKYE)

Role
Director
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
Stock symbol
SKYE
Transactions as of
Feb 29, 2024
Transactions value $
$0
Form type
3
Date filed
3/4/2024, 04:18 PM
Previous filing
Feb 9, 2024
Next filing
May 3, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney